文献速递生殖医学妇科

人类排卵期颗粒细胞转录组的两波变化

Two waves of transcriptomic changes in periovulatory human granulosa cells.
PubMed 文献 · Hum Reprod · 2020-01-01

该前瞻性队列研究纳入50名接受拮抗剂方案促排卵的女性,在诱导排卵前及后12、17、32、36小时采集颗粒细胞行微阵列分析,发现排卵后12小时和36小时出现两个转录峰,均以炎症相关基因和通路为主。

要点

  • 排卵后12小时和36小时出现两个转录峰,均以炎症系统基因和通路为主。
  • 下调基因主要涉及细胞周期和DNA修复通路。
  • 36小时上调基因涉及血管扩张、血管生成、凝血、趋化及组织重塑等炎症效应功能。

核心结论

  • 人类排卵期颗粒细胞转录组呈现两个转录峰,分别在诱导排卵后12小时和36小时,均由炎症系统基因和通路主导。

研究设计与样本

  • 前瞻性队列研究,纳入50名在大学医院附属生育诊所接受标准拮抗剂方案促排卵的女性,2016-2018年。
  • 每名女性在诱导排卵前或后12、17、32小时经阴道超声引导卵泡穿刺采集一份颗粒细胞样本,取卵时(诱导排卵后36小时)采集第二份样本。
  • 颗粒细胞总RNA行微阵列分析,五个时间点间基因表达差异用ANOVA评估,随机因子考虑样本配对,鉴定出七个代表不同表达谱的蛋白编码基因簇。

主要发现

  • 两个主要下调基因簇代表细胞周期通路和DNA修复。
  • 上调基因在12小时出现一个峰,类似炎症反应启动;在36小时出现一个峰,类似炎症效应功能如血管扩张、血管生成、凝血、趋化及组织重塑。
  • 36小时参与细胞-基质相互作用(作为细胞骨架重排和细胞运动的一部分)的基因也上调。
  • 预测的排卵上游激活调控因子包括FSH、LH、转化生长因子B1、肿瘤坏死因子、核因子κB、凝血因子2、成纤维细胞生长因子2、白细胞介素1和皮质醇等。

临床怎么用

  • 研究加深了对人类排卵期卵巢功能的理解,公开数据集(GSE133868)可作为未来研究的宝贵资源。
  • 预测的上游调控因子和高差异表达基因可能成为生育治疗和妇科的潜在药物靶点。

局限性

  • 研究纳入接受卵巢刺激的女性, findings可能与自然周期不同。
  • 结果证实了先前研究中许多公认排卵基因(如双调蛋白、表皮调节素、肿瘤坏死因子α诱导蛋白6、金属肽酶抑制剂1和纤溶酶原激活物抑制剂1)的显著调控,支持结果相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How does the human granulosa cell (GC) transcriptome change during ovulation? SUMMARY ANSWER: Two transcriptional peaks were observed at 12 h and at 36 h after induction of ovulation, both dominated by genes and pathways known from the inflammatory system. WHAT IS KNOWN ALREADY: The crosstalk between GCs and the oocyte, which is essential for ovulation and oocyte maturation, can be assessed through transcriptomic profiling of GCs. Detailed transcriptional changes during ovulation have not previously been assessed in humans. STUDY DESIGN, SIZE, DURATION: This prospective cohort study comprised 50 women undergoing fertility treatment in a standard antagonist protocol at a university hospital-affiliated fertility clinic in 2016-2018. PARTICIPANTS/MATERIALS, SETTING, METHODS: From each woman, one sample of GCs was collected by transvaginal ultrasound-guided follicle aspiration either before or 12 h, 17 h or 32 h after ovulation induction (OI). A second sample was collected at oocyte retrieval, 36 h after OI. Total RNA was isolated from GCs and analyzed by microarray. Gene expression differences between the five time points were assessed by ANOVA with a random factor accounting for the pairing of samples, and seven clusters of protein-coding genes representing distinct expression profiles were identified. These were used as input for subsequent bioinformatic analyses to identify enriched pathways and suggest upstream regulators. Subsets of genes were assessed to explore specific ovulatory functions. MAIN RESULTS AND THE ROLE OF CHANCE: We identified 13 345 differentially expressed transcripts across the five time points (false discovery rate, <0.01) of which 58% were protein-coding genes. Two clusters of mainly downregulated genes represented cell cycle pathways and DNA repair. Upregulated genes showed one peak at 12 h that resembled the initiation of an inflammatory response, and one peak at 36 h that resembled the effector functions of inflammation such as vasodilation, angiogenesis, coagulation, chemotaxis and tissue remodelling. Genes involved in cell-matrix interactions as a part of cytoskeletal rearrangement and cell motility were also upregulated at 36 h. Predicted activated upstream regulators of ovulation included FSH, LH, transforming growth factor B1, tumour necrosis factor, nuclear factor kappa-light-chain-enhancer of activated B cells, coagulation factor 2, fibroblast growth factor 2, interleukin 1 and cortisol, among others. The results confirmed early regulation of several previously described factors in a cascade inducing meiotic resumption and suggested new factors involved in cumulus expansion and follicle rupture through co-regulation with previously described factors. LARGE SCALE DATA: The microarray data were deposited to the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/gds/, accession number: GSE133868). LIMITATIONS, REASONS FOR CAUTION: The study included women undergoing ovarian stimulation and the findings may therefore differ from a natural cycle. However, the results confirm significant regulation of many well-established ovulatory genes from a series of previous studies such as amphiregulin, epiregulin, tumour necrosis factor alfa induced protein 6, tissue inhibitor of metallopeptidases 1 and plasminogen activator inhibitor 1, which support the relevance of the results. WIDER IMPLICATIONS OF THE FINDINGS: The study increases our understanding of human ovarian function during ovulation, and the publicly available dataset is a valuable resource for future investigations. Suggested upstream regulators and highly differentially expressed genes may be potential pharmaceutical targets in fertility treatment and gynaecology. STUDY FUNDING/COMPETING INTEREST(S): The study was funded by EU Interreg ÔKS V through ReproUnion (www.reprounion.eu) and by a grant from the Region Zealand Research Foundation. None of the authors have any conflicts of interest to declare.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Poulsen LC, Bøtkjær JA, Østrup O, et al. Two waves of transcriptomic changes in periovulatory human granulosa cells. Hum Reprod. 2020. PMID: 32378719. doi:10.1093/humrep/deaa043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。